Intrinsic Value of S&P & Nasdaq Contact Us

Alimera Sciences, Inc. ALIM NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
35/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.75
+3.8%

Stock Statistics — ALIM

Alimera Sciences, Inc. (ALIM) has a market capitalization of $301.29M and trades at $5.54. The 52-week range is 2.606-5.65.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -7, Earnings Per Share (EPS) of $-0.79, annual revenue of $80.75M.

The stock has a beta of 1.25, operates in the Healthcare sector.

Trading Data
Current Price$5.54
52-Week Range2.606-5.65
Volume2.68M
Avg Volume (30D)866.83K
Market Cap$301.29M
Beta (1Y)1.25
Company
IPO Date2019-11-04
Employees154
CEORichard S. Eiswirth Jr.
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS0162592028
CUSIP016259202
Income (Latest Year)
Revenue$80.75M
Gross Profit$61.17M
EBITDA$-1.12M
Operating Income$-1.93M
Net Income$-20.13M
EPS$-0.79
EPS Diluted$-0.79
Shares Outstanding$25.56M
Balance Sheet (Latest Year)
Total Assets$153.52M
Current Assets$52.42M
Cash & ST Investments$12.09M
Total Liabilities$107.35M
Total Debt$67.4M
Net Debt$55.31M
Total Equity$46.17M
Debt / Equity1.46
Valuation Ratios
P/E Ratio-7
P/S Ratio3.73
P/B Ratio6.53
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message